No abstract available
MeSH terms
-
Adolescent
-
Advisory Committees
-
Antidepressive Agents, Second-Generation / adverse effects*
-
Antidepressive Agents, Second-Generation / therapeutic use
-
Anxiety Disorders / drug therapy
-
Child
-
Controlled Clinical Trials as Topic
-
Depressive Disorder / drug therapy
-
Humans
-
Product Surveillance, Postmarketing
-
Risk Factors
-
Selective Serotonin Reuptake Inhibitors / adverse effects*
-
Selective Serotonin Reuptake Inhibitors / therapeutic use
-
Suicide*
-
United Kingdom
-
United States
-
United States Food and Drug Administration*
Substances
-
Antidepressive Agents, Second-Generation
-
Serotonin Uptake Inhibitors